Correlation Between Bristol-Myers Squibb and Hypercharge Networks

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol-Myers Squibb and Hypercharge Networks at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol-Myers Squibb and Hypercharge Networks into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Hypercharge Networks Corp, you can compare the effects of market volatilities on Bristol-Myers Squibb and Hypercharge Networks and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol-Myers Squibb with a short position of Hypercharge Networks. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol-Myers Squibb and Hypercharge Networks.

Diversification Opportunities for Bristol-Myers Squibb and Hypercharge Networks

-0.86
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Bristol-Myers and Hypercharge is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Hypercharge Networks Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hypercharge Networks Corp and Bristol-Myers Squibb is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Hypercharge Networks. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hypercharge Networks Corp has no effect on the direction of Bristol-Myers Squibb i.e., Bristol-Myers Squibb and Hypercharge Networks go up and down completely randomly.

Pair Corralation between Bristol-Myers Squibb and Hypercharge Networks

Assuming the 90 days horizon Bristol Myers Squibb is expected to generate 0.43 times more return on investment than Hypercharge Networks. However, Bristol Myers Squibb is 2.35 times less risky than Hypercharge Networks. It trades about 0.0 of its potential returns per unit of risk. Hypercharge Networks Corp is currently generating about -0.02 per unit of risk. If you would invest  117,420  in Bristol Myers Squibb on September 3, 2024 and sell it today you would lose (16,865) from holding Bristol Myers Squibb or give up 14.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy46.95%
ValuesDaily Returns

Bristol Myers Squibb  vs.  Hypercharge Networks Corp

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile primary indicators, Bristol-Myers Squibb reported solid returns over the last few months and may actually be approaching a breakup point.
Hypercharge Networks Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hypercharge Networks Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Bristol-Myers Squibb and Hypercharge Networks Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol-Myers Squibb and Hypercharge Networks

The main advantage of trading using opposite Bristol-Myers Squibb and Hypercharge Networks positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol-Myers Squibb position performs unexpectedly, Hypercharge Networks can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hypercharge Networks will offset losses from the drop in Hypercharge Networks' long position.
The idea behind Bristol Myers Squibb and Hypercharge Networks Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
CEOs Directory
Screen CEOs from public companies around the world
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets